Cacace Angela M Insider Trading Activity (ARVN)

Summary

Updated Jul 16, 2026

Cacace Angela M has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $214K.

Profile

Angela M. Cacace is the Chief Scientific Officer at Arvinas, Inc., a biotechnology company focused on developing therapies for cancer and other diseases through protein degradation technology. She has extensive experience in drug discovery and development, with a strong background in molecular biology and biochemistry.

Role	Chief Scientific Officer
Notability	75/100

Board memberships

Arvinas, Inc.

Awards & honors

Leadership in drug discovery at Arvinas
Development of innovative protein degradation therapies

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-18	ARVN	ARVINAS, INC.	S — Open-market sale	2.6K	$7.59	$20K
2026-05-13	ARVN	ARVINAS, INC.	S — Open-market sale	9.7K	$9.94	$96K
2026-03-03	ARVN	ARVINAS, INC.	A — Grant or award	45.0K	$0.00
2026-02-25	ARVN	ARVINAS, INC.	S — Open-market sale	2.6K	$12.16	$31K
2026-02-25	ARVN	ARVINAS, INC.	S — Open-market sale	1.0K	$12.16	$13K
2026-02-18	ARVN	ARVINAS, INC.	S — Open-market sale	4.6K	$11.89	$55K

Frequently Asked Questions

Who is Cacace Angela M?

How many SEC Form 4 filings has Cacace Angela M submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Cacace Angela M been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($214K) across all tracked filings.

Where can I see all of Cacace Angela M's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Cacace Angela M — SEC Form 4 Insider Trading Activity